Cargando…
A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes
Background: Lymphangioleiomyomatosis (LAM) is a rare systemic disease that generally leads to a progressive decline in pulmonary function. Experience, especially from the Asian population, including combined drug therapy before and after lung transplantation (LT) in LAM, is still limited. This study...
Autores principales: | Zhang, Ji, Liu, Dong, Yue, Bingqing, Ban, Le, Zhou, Min, Wang, Hongmei, Lv, Jian, Wu, Bo, Zhai, Zhenguo, Xu, Kai-Feng, Chen, Wenhui, Chen, Jingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924661/ https://www.ncbi.nlm.nih.gov/pubmed/33665195 http://dx.doi.org/10.3389/fmed.2021.584826 |
Ejemplares similares
-
Lung Transplantation for Lymphangioleiomyomatosis in Japan
por: Ando, Katsutoshi, et al.
Publicado: (2016) -
Lymphangioleiomyomatosis: Searching for potential biomarkers
por: Revilla-López, Eva, et al.
Publicado: (2023) -
Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment
por: Song, Xixi, et al.
Publicado: (2020) -
An entity that poses continuous challenge despite treatment attempt: lymphangioleiomyomatosis
por: Sharma, Munish, et al.
Publicado: (2020) -
Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases
por: Bernardelli, Clara, et al.
Publicado: (2023)